TD Asset Management
MIRM icon

TD Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

TD Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.11M Buy
33,688
+10,412
+45% +$979K ﹤0.01% 877
2025
Q4 		$1.84M Buy
23,276
+7,876
+51% +$565K ﹤0.01% 1005
2025
Q3 		$1.13M Buy
+15,400
New +$979K ﹤0.01% 1069
2024
Q2 		– Sell
-59,800
Closed -$1.5M – 1400
2024
Q1 		$1.5M Buy
59,800
+12,800
+27% +$352K ﹤0.01% 1094
2023
Q4 		$1.39M Buy
+47,000
New +$1.42M ﹤0.01% 1108

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

TD Asset Management's MIRM Position: Q1 2026 in Review

TD Asset Management increased its Mirum Pharmaceuticals (MIRM) stake by 45% in Q1 2026, buying an estimated $979K and bringing the position to 33,688 shares worth $3.11M. The position accounts for ﹤0.01% of the portfolio, ranked #877.

TD Asset Management first reported a position in MIRM in Q4 2023 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • TD Asset Management held 33,688 shares of Mirum Pharmaceuticals worth $3.11M as of Q1 2026.
  • TD Asset Management bought 10,412 Mirum Pharmaceuticals shares in Q1 2026, an estimated $979K.
  • Mirum Pharmaceuticals made up ﹤0.01% of TD Asset Management's portfolio in Q1 2026, its #877 holding.
  • TD Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.